PDT Partners, LLC - PUMA BIOTECHNOLOGY INC ownership

PUMA BIOTECHNOLOGY INC's ticker is PBYI and the CUSIP is 74587V107. A total of 79 filers reported holding PUMA BIOTECHNOLOGY INC in Q1 2023. The put-call ratio across all filers is 0.15 and the average weighting 0.0%.

Quarter-by-quarter ownership
PDT Partners, LLC ownership history of PUMA BIOTECHNOLOGY INC
ValueSharesWeighting
Q2 2023$77,469
+14.2%
21,9460.0%0.01%
+22.2%
Q1 2023$67,813
-16.3%
21,946
+14.6%
0.01%
-30.8%
Q4 2022$80,988
-39.6%
19,146
-58.8%
0.01%
+8.3%
Q1 2022$134,000
-35.3%
46,494
-31.7%
0.01%
-25.0%
Q4 2021$207,000
-55.8%
68,091
+2.0%
0.02%
-52.9%
Q3 2021$468,000
-22.9%
66,728
+0.9%
0.03%
-15.0%
Q2 2021$607,000
-13.0%
66,122
-8.0%
0.04%
-20.0%
Q1 2021$698,000
-17.0%
71,855
-12.3%
0.05%
-12.3%
Q4 2020$841,000
-35.1%
81,960
-36.1%
0.06%
-33.7%
Q3 2020$1,295,000
-34.1%
128,318
-31.9%
0.09%
-35.8%
Q2 2020$1,966,000
+14.0%
188,538
-7.7%
0.13%
-2.2%
Q1 2020$1,724,000
+17.5%
204,238
+21.9%
0.14%
+52.2%
Q4 2019$1,467,000
-45.6%
167,600
-33.1%
0.09%
-43.8%
Q3 2019$2,696,000
+13.0%
250,409
+33.4%
0.16%
+13.5%
Q2 2019$2,386,000
-49.6%
187,700
+53.7%
0.14%
-47.4%
Q1 2019$4,736,000
+90.5%
122,100
-0.0%
0.27%
+92.8%
Q4 2018$2,486,000
+476.8%
122,150
+3208.5%
0.14%
+1163.6%
Q2 2015$431,000
-19.1%
3,692
-62.8%
0.01%
-21.4%
Q3 2013$533,000
+59.1%
9,924
+31.5%
0.01%
+55.6%
Q2 2013$335,0007,5450.01%
Other shareholders
PUMA BIOTECHNOLOGY INC shareholders Q1 2023
NameSharesValueWeighting ↓
Athyrium Capital Management, LP 1,792,114$5,108,0002.15%
Camber Capital Management LP 4,235,000$12,070,0000.52%
Kynam Capital Management, LP 579,915$1,653,0000.42%
GLOBEFLEX CAPITAL L P 419,322$1,195,0000.29%
Eversept Partners, LP 1,435,077$4,089,9690.29%
ARMISTICE CAPITAL, LLC 1,500,000$4,275,0000.08%
RICE HALL JAMES & ASSOCIATES, LLC 506,066$1,442,0000.07%
XTX Topco Ltd 36,130$103,0000.04%
State of Wyoming 20,732$59,0000.04%
Patriot Financial Group Insurance Agency, LLC 55,500$158,0000.03%
View complete list of PUMA BIOTECHNOLOGY INC shareholders